Gerdes Anne-Marie, Vogel Ida
Klinisk Genetisk Klinik, Rigshospitalet, Blegdamsvej 9, 2100 København Ø.
Ugeskr Laeger. 2014 Nov 10;176(46).
Next generation sequencing, a remarkable progress in medical genetics, analyses the exome for disease-causing mutations (exome sequencing) especially in cases with genetic heterogeneity or cases where single gene approach has not revealed the diagnosis. Many unsolved questions exist such as unsolicited findings in genes not related to the patients' symptoms or variants of unknown significance. Informed consent is crucial before analysis but post-test genetic counselling and strategies for reporting back results to family members are necessary.
下一代测序技术是医学遗传学领域的一项重大进展,它通过分析外显子组来寻找致病突变(外显子组测序),尤其适用于存在遗传异质性的病例或采用单基因方法未能明确诊断的病例。然而,该技术仍存在许多未解决的问题,例如在与患者症状无关的基因中发现意外结果,或者存在意义未明的变异。在进行分析之前,获得知情同意至关重要,而且检测后的遗传咨询以及向家庭成员反馈结果的策略也必不可少。